Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pCDH-Flag-c-Myc Citations (6)

Originally described in: A SIRT2-Selective Inhibitor Promotes c-Myc Oncoprotein Degradation and Exhibits Broad Anticancer Activity.
Jing H, Hu J, He B, Negron Abril YL, Stupinski J, Weiser K, Carbonaro M, Chiang YL, Southard T, Giannakakou P, Weiss RS, Lin H Cancer Cell. 2016 Mar 14;29(3):297-310. doi: 10.1016/j.ccell.2016.02.007.
PubMed Journal

Articles Citing pCDH-Flag-c-Myc

Articles
The splicing regulatory factor hnRNPU is a novel transcriptional target of c-Myc in hepatocellular carcinoma. Zhang B, Wang HY, Zhao DX, Wang DX, Zeng Q, Xi JF, Nan X, He LJ, Zhou JN, Pei XT, Yue W. FEBS Lett. 2021 Jan;595(1):68-84. doi: 10.1002/1873-3468.13943. Epub 2020 Nov 7. PubMed
The folate cycle enzyme MTHFD2 induces cancer immune evasion through PD-L1 up-regulation. Shang M, Yang H, Yang R, Chen T, Fu Y, Li Y, Fang X, Zhang K, Zhang J, Li H, Cao X, Gu J, Xiao J, Zhang Q, Liu X, Yu Q, Wang T. Nat Commun. 2021 Mar 29;12(1):1940. doi: 10.1038/s41467-021-22173-5. PubMed
The c-Myc/TBX3 Axis Promotes Cellular Transformation of Sarcoma-Initiating Cells. Damerell V, Ambele MA, Salisbury S, Neumann-Mufweba A, Durandt C, Pepper MS, Prince S. Front Oncol. 2022 Jan 25;11:801691. doi: 10.3389/fonc.2021.801691. eCollection 2021. PubMed
A Functional Screening Identifies a New Organic Selenium Compound Targeting Cancer Stem Cells: Role of c-Myc Transcription Activity Inhibition in Liver Cancer. Zhou JN, Zhang B, Wang HY, Wang DX, Zhang MM, Zhang M, Wang XK, Fan SY, Xu YC, Zeng Q, Jia YL, Xi JF, Nan X, He LJ, Zhou XB, Li S, Zhong W, Yue W, Pei XT. Adv Sci (Weinh). 2022 Aug;9(22):e2201166. doi: 10.1002/advs.202201166. Epub 2022 Jun 2. PubMed
CRL2(ZER1/ZYG11B) recognizes small N-terminal residues for degradation. Li Y, Zhao Y, Yan X, Ye C, Weirich S, Zhang B, Wang X, Song L, Jiang C, Jeltsch A, Dong C, Mi W. Nat Commun. 2022 Dec 10;13(1):7636. doi: 10.1038/s41467-022-35169-6. PubMed
UPR-Induced miR-616 Inhibits Human Breast Cancer Cell Growth and Migration by Targeting c-MYC. Arabkari V, Sultana A, Barua D, Webber M, Smith T, Gupta A, Gupta S. Int J Mol Sci. 2023 Aug 22;24(17):13034. doi: 10.3390/ijms241713034. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.